Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dogliotti

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Anticancer Research|November 1, 1995
Biochemical picture of bone metabolism in breast cancer patients with bone metastasesA Berruti, M Torta, A Piovesan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanismE Bellini, A Pia, M P Brizzi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1994
Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer riskA Angeli, L Dogliotti, C Naldoni, et al.
British Journal of Cancer|December 22, 2004
Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancerA Sobrero, G Frassineti, A Falcone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 23, 2009
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimenF Vignani, L Russo, M Tucci, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric studyD Beccati, N Grilli, P Schincaglia, et al.
Oncology Reports|June 16, 2000
Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatmentA Berruti, L Dogliotti, G Osella, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancerM Terzolo, A Pia, A Berruti, et al.
Minerva Pediatrica|October 23, 2001
[The transition from pediatrics to adult medicine in patients recovered after an infantile neoplasm]R Miniero, L Cordero Di Montezemolo, L Dogliotti, et al.
The Prostate|May 15, 2001
Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patientsA Berruti, L Dogliotti, A Mosca, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Anticancer Research|November 1, 1995
Biochemical picture of bone metabolism in breast cancer patients with bone metastasesA Berruti, M Torta, A Piovesan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanismE Bellini, A Pia, M P Brizzi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1994
Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer riskA Angeli, L Dogliotti, C Naldoni, et al.
British Journal of Cancer|December 22, 2004
Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancerA Sobrero, G Frassineti, A Falcone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 23, 2009
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimenF Vignani, L Russo, M Tucci, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric studyD Beccati, N Grilli, P Schincaglia, et al.
Oncology Reports|June 16, 2000
Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatmentA Berruti, L Dogliotti, G Osella, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancerM Terzolo, A Pia, A Berruti, et al.
Minerva Pediatrica|October 23, 2001
[The transition from pediatrics to adult medicine in patients recovered after an infantile neoplasm]R Miniero, L Cordero Di Montezemolo, L Dogliotti, et al.
The Prostate|May 15, 2001
Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patientsA Berruti, L Dogliotti, A Mosca, et al.
Pageof 15